首页> 外文会议>Pacific Rim Meeting on Electrochemical and Solid-State Science >Development of a 3D Printed Refillable Drug Delivery Device for Sustained Release to the Retina
【24h】

Development of a 3D Printed Refillable Drug Delivery Device for Sustained Release to the Retina

机译:用于持续释放到视网膜的3D印刷的可再填充药物递送装置的开发

获取原文

摘要

Retinal degenerative diseases (RDD) such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP) cause progressive loss of vision, affecting millions of people worldwide. Drug delivery system (DDS) such as vitreous injection and intraocular implant has been widely investigated to treat RDD. However, they are invasive and can risk infection of the eye. Thus, we have been working on the development of transscleral DDS, which are less invasive and can achieve more localized release of drug than the conventional methods. We have previously reported capsule-type and sheet-type DDS devices that can be implanted on the transscleral (periocular) region of the eye. However, such devices need to be replaced once drug run out. Herein, we report a 3D printed refillable DDS device for long term delivery of drugs to the retina.
机译:视网膜退行性疾病(RDD)如年龄相关的黄斑变性(AMD)和视网膜炎(RP)导致视力逐渐丧失,影响全世界数百万人。 诸如玻璃体注射和眼内植入物的药物递送系统(DDS)已被广泛研究以治疗RDD。 然而,它们是侵入性的并且可以冒着眼睛的感染。 因此,我们一直在努力开发过态DDS,其侵入性较少,并且可以实现比常规方法更少的药物释放。 我们先前已经报道过胶囊型和片材型DDS装置,其可以植入眼睛的外囊(周围)区域。 然而,一旦药物用完,需要更换这样的装置。 在此,我们报告了一种3D印刷的可再填充DDS装置,用于长期将药物递送到视网膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号